Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,069
Closed -$686K 144
2024
Q4
$686K Sell
1,069
-1,070
-50% -$47.9K 0.05% 95
2024
Q3
$1.01M Hold
2,139
0.09% 75
2024
Q2
$845K Buy
+2,139
New +$93.8K 0.07% 79

Other funds holding QGEN

DNCA Finance's QGEN Position: Q1 2026 in Review

DNCA Finance increased its Qiagen (QGEN) stake by 9.8% in Q1 2026, buying an estimated $3.21M and bringing the position to 759,564 shares worth $30.4M. The position accounts for 1.74% of the portfolio, ranked #17.

DNCA Finance first reported a position in QGEN in Q2 2024 and has held it in 8 quarters since. The position peaked at $31.6M in Q4 2025. 343 funds tracked by Wall St. Rank hold QGEN as of Q1 2026.

  • DNCA Finance held 759,564 shares of Qiagen worth $30.4M as of Q1 2026.
  • DNCA Finance bought 67,743 Qiagen shares in Q1 2026, an estimated $3.21M.
  • Qiagen made up 1.74% of DNCA Finance's portfolio in Q1 2026, its #17 holding.
  • DNCA Finance first reported a position in Qiagen in Q2 2024 and has held it in 8 quarters since.
  • DNCA Finance's Qiagen position peaked at $31.6M in Q4 2025.
  • 343 funds tracked by Wall St. Rank held Qiagen as of Q1 2026.

Based on DNCA Finance's 13F filing for Q1 2026, filed 14 May 2026.